1016/j.jvs.2020.01.039

Thomas L. Forbes (Chair), Ruth Bush (Vice-Chair), Neal Barshes, Keith Calligaro, Ronald L. Dalman, Mark Davies, Yazan Duwayri, Alik Farber, Gregory

3S

4S

Chaer et al

Journal of Vascular Surgery
July Supplement 2020

Technical remark: Non-contrast-enhanced MRA is best
suited to children and women of childbearing potential
or those who have contraindications to CTA or MRA
contrast materials (ie, pregnancy, renal insufï¬ciency, or
gadolinium contrast material allergy).
1.3: We recommend the use of catheter-based angiography both for preoperative planning and to better delineate distal renal artery branches that may be
inadequately assessed on conventional cross-sectional
imaging. Level of recommendation: Grade 1 (Strong),
Quality of Evidence: C (Low).
2.1: In patients with noncomplicated RAA of acceptable
operative risk, we suggest treatment for aneurysm size
>3 cm. Level of recommendation: Grade 2 (Weak),
Quality of Evidence: C (Low).
2.2: We recommend emergent intervention for any size
RAA resulting in patient symptoms or rupture. Level of
recommendation: Grade 1 (Strong), Quality of
Evidence: B (Moderate).
2.3: In patients of childbearing potential with noncomplicated RAA of acceptable operative risk, we suggest
treatment regardless of size. Level of recommendation:
Grade 2 (Weak), Quality of Evidence: B (Moderate).
2.4: In patients with medically refractory hypertension
and functionally important renal artery stenosis, we suggest treatment regardless of size. Level of recommendation: Grade 2 (Weak), Quality of Evidence: C (Low).
3.1: We suggest daily antiplatelet therapy (ie, aspirin,
81 mg) for patients with RAA. Level of recommendation:
Grade 2 (Weak), Quality of Evidence: C (Low).
3.2: We suggest open surgical reconstructive techniques for the elective repair of most RAAs in patients
with acceptable operative risk. Level of recommendation: Grade 2 (Weak), Quality of Evidence: B (Moderate